Topical glucocorticoids: what has been achieved? What is still to be done?
Schäfer-Korting
M
M
Pharmakologisches Institut für Naturwissenschaftler der Johann-Wolfgang-Goethe-Universität, Frankfurt/Main, BRD.
D000287:Administration, Topical; D001284:Atrophy; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008081:Liposomes; D014677:Pharmaceutical Vehicles; D010913:Pituitary-Adrenal System / Q000187:drug effects; D012176:Retinoids / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000473:pathology
D005938:Glucocorticoids; D008081:Liposomes; D014677:Pharmaceutical Vehicles; D012176:Retinoids